Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

Nadia OvchinskyMadeleine AumarAlastair BakerUlrich BaumannPhilip BuflerMara CananziPiotr CzubkowskiÖzlem DurmazRyan FischerGiuseppe IndolfiWikrom W KarnsakulFlorence LacailleWay S LeeGiuseppe MaggiorePhilip RosenthalMathias RuizEtienne SokalEkkehard SturmWendy van der WoerdHenkjan J VerkadeAndrew WehrmanChristine ClemsonQifeng YuQuanhong NiJessica RuvidoSusan ManganaroJan P Mattsson2024-10-172024-10-172024-0710.1016/S2468-1253(24)00074-8https://dspace-cris.utar.edu.my/handle/123456789/3100Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trialjournal-article